Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LABORATORY CORPORATION OF AMERICA HOLDINGS

(LH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Laboratory of America : Labcorp Builds New Bioanalytical Lab in Singapore

05/20/2021 | 06:47am EDT


© MT Newswires 2021
All news about LABORATORY CORPORATION OF AMERICA HOLDINGS
07/30LABORATORY OF AMERICA : Deutsche Bank Adjusts Laboratory Corp of America Holding..
MT
07/30LABORATORY OF AMERICA : Mizuho Securities Adjusts Price Target on Laboratory Cor..
MT
07/29SECTOR UPDATE : Health Care Stocks Closing Slightly Higher
MT
07/29SECTOR UPDATE : Health Care Stocks Inching Higher This Afternoon
MT
07/29LABORATORY OF AMERICA : Labcorp Announces 2021 Second Quarter Results Company Ra..
PU
07/29LABORATORY OF AMERICA : Posts Increase in Q2 Adjusted Earnings, Revenue; Raises ..
MT
07/29LABCORP : Q2 Earnings Snapshot
AQ
07/29LABCORP : Announces 2021 Second Quarter Results
BU
07/29LABORATORY OF AMERICA : Earnings Flash (LH) LABCORP Reports Q2 Revenue $3.84B, v..
MT
07/29LABORATORY OF AMERICA : Earnings Flash (LH) LABCORP Posts Q2 EPS $6.13, vs. Stre..
MT
More news
Financials (USD)
Sales 2021 15 003 M - -
Net income 2021 1 915 M - -
Net Debt 2021 3 556 M - -
P/E ratio 2021 15,1x
Yield 2021 -
Capitalization 28 638 M 28 638 M -
EV / Sales 2021 2,15x
EV / Sales 2022 2,27x
Nbr of Employees 70 000
Free-Float 99,0%
Chart LABORATORY CORPORATION OF AMERICA HOLDINGS
Duration : Period :
Laboratory Corporation of America Holdings Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LABORATORY CORPORATION OF AMERICA HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 296,15 $
Average target price 310,14 $
Spread / Average Target 4,72%
EPS Revisions
Managers and Directors
Adam H. Schechter Chairman, President & Chief Executive Officer
Glenn Andrew Eisenberg Chief Financial Officer & Executive Vice President
Lance V. Berberian Chief Information & Technology Officer & EVP
Brian J. Caveney Chief Medical Officer, EVP & President-Diagnostics
Stephen M. Anderson Chief Scientific Officer-Covance & Senior VP